October Pharma is investing EGP 30 mn to upgrade its production lines in order to increase exports this year, according to CEO Ahmed Zaghloul. The company will work on growing sales in existing markets such as Russia, as well as entering new markets in Africa and Turkey.
More from Enterprise
Inflation unexpectedly cools, putting rate-cut cycle back in play
The first fall in the headline rate in three months…
Qatar’s Green Sky Capital secures financing for USD 200 mn SAF plant
The facility could add more than 10% to global SAF…
New tax bill heads to House ahead of July rollout
The new package scraps the contentious capital gains tax, overhauls…
Kiwe gets Central Bank green light to launch nationwide
The startup is backed by our friends at EFG Hermes,…